×
For best experience we recommend to activate Javascript in your browser.
Recombinant TCP1 alpha/CCTA antibody (C-Term)
The Rabbit Monoclonal anti-TCP1 alpha/CCTA antibody (Clone RM383) (ABIN7670465) specifically detects TCP1 alpha/CCTA in WB and IHC.
The antibody is reactive with Human samples.
Catalog No. ABIN7670465
$452.00
Plus shipping costs $50.00
Delivery in 1 to 2 Business Days
Quick Overview for Recombinant TCP1 alpha/CCTA antibody (C-Term) (ABIN7670465)
Target
See all TCP1 alpha/CCTA (TCP1) Antibodies
TCP1 alpha/CCTA (TCP1)
(T-Complex 1 (TCP1))
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for TCP1 alpha/CCTA antibodies
Human
Host
All hosts for TCP1 alpha/CCTA antibodies
Rabbit
Clonality
All clonalities for TCP1 alpha/CCTA antibodies
Monoclonal
Conjugate
All conjugates for TCP1 alpha/CCTA antibodies
This TCP1 alpha/CCTA antibody is un-conjugated
Application
All applications for TCP1 alpha/CCTA antibodies
Western Blotting (WB), Immunohistochemistry (IHC)
Clone
RM383
Product Details anti-TCP1 alpha/CCTA Antibody
(hide)
Binding Specificity
All epitopes for TCP1 alpha/CCTA antibodies
C-Term
Purpose
Rabbit monoclonal to p63 (Tumor protein 63)
Specificity
This antibody reacts to human p63 (Tumor protein 63).
Purification
Protein A affinity purified from an animal origin-free culture supernatant
Immunogen
A peptide corresponding to the area surrounding the C-terminus of human p63 (Tumor protein 63).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Immunohistochemistry (IHC): 1:100-1:200 dilution, WB: 1:500-1:1000 dilution.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
50 % Glycerol/PBS with 1 % BSA and 0.09 % sodium azide
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20.0°C
Target Details for TCP1 alpha/CCTA
(hide)
Target
TCP1 alpha/CCTA (TCP1)
(T-Complex 1 (TCP1))
Alternative Name
p63
Gene ID
8626
Recently viewed
(hide)
Chat with us , powered by LiveChat